 |
| Arne Simon, Roland A. Ammann, Gertrud Wiszniewsky, Udo Bode, Gudrun Fleischhack, Mette M. Besuden |
 |
|
Taurolidine-citrate lock-solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients; 29 July 2008 BMC Infectious Diseases |
|
| Caroline Taylor, John Cahill, Martin Gerrish, Jane Little |
|
|
A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients Journal of Renal Care, 34(3), 116-120 |
|
| Quarello, F.Forneris, G. |
|
|
Prevention of Hemodialysis Catheter-Related Bloodstream Infection Using an Antimicrobial Lock, Blood Purif. 2002; 20:87-92. |
|
| Jurewitsch, Khursheed N. Jeejeebhoy |
|
|
Taurolidine lock: The key to prevention of recurrent catheter-related bloodstream infections. Clinical Nutrition (2005) 24, 462-465. |
|
| Sodemann, K. Polaschegg, H.-D. Feldmer, B. |
|
|
Two Years` Experience with Dialock and CLS ™ (A New Antimicrobial Lock Solution), Blood Purif. 2001; 19:251-254. |
|
| Torres-Viera, C., et al. |
|
|
Activities of Taurolidine in Vitro and in Experimental Enterococcal Endocarditis, Antimicrob. Agents Chemother. 2000, 44: 1720-1724. |
|
| Shah, C. B., Mittelman, M. W., Costerton, J. W., Parenteau, A. S., Pelak, |
|
|
Antimicrobial Activity of a Novel Catheter Lock Solution, Antimicrob. Agents Chemother. 2002, 46: 1674-1679. |
|
| Allon, M. |
|
|
Prophylaxis against Dialysis Catheter-Related Bacteremia with a Novel Antimicrobial Lock Solution, Clin. Infect. Dis. 2003,: 1539-1544.
|
|
| Gorke, A. |
|
|
Mikrobiologische Kontamination von Hämodialyse- Katheter-Anschlüssen, Nephrol. Team, 2003, 2:88-92. |
|
| Vogel-Kahmann, I., Conrad, C. |
|
|
Zentralvenöse Katheter und Taurolidin die Katheter- Lock-Lösung der Zukunft? € Hygiene Aktuell, 2003, 25, 3:128-131. |
|
| Polaschegg, H.-D., Sodemann, K. |
|
|
Risks Related to Catheter Locking Solutions containing Concentrated Citrate, Nephrol. Dial. Transplant. 2003, 18:2688-2690.
|
|
| Betjes, M. G. H., van Agteren, M. |
|
|
Prevention of Dialysis Catheter-Related Sepsis with a Citrate-Taurolidine-containing Lock Solution, Nephrol Dial Transplant, 2004, 19:1546-1551. |
|
| Koldehoff, M., Zakrzewski, J. L. |
|
|
Taurolidine is Effective in the Treatment of Central Venous Catheter-related Bloodstream Infections in Cancer Patients, Int. J. Antimicrob. Agents, 2004, 24:491-495. |
|
| Srivastava, R.,Murphy,M. J.,Card, J.,Sever, A.,Fraser,C. G. |
|
|
The Case of the Floating Gel € J. Clin. Pathol., 2004, 57:1333-1334. |
|
| Simon Desmeules and Bernard Canaud |
|
|
Venous Access for Chronic Hemodialysis:
"Undesiable Yet Unavoidable", Artifical Organs 28(7): 611-616 2004 |
|
| C.D Punt and W.E. Boer |
|
|
Cardiac arrest following injection of concentrated trisodium citrate; Intensive Care Unit, Atrium Medisch Centrum, Heerlen, The Netherlands |
|
| Laurie R. Solomon,FRCP John S. Cheesbrough;FRCPath, Leonard Ebah, MRCP |
|
|
A randomized double-blind controlled trial of Taurolidine-Citrate catheter locks for the prevention of bacteremis in patients treated with hemodialysis; 2010 National Kidney Foundation |
|
|
|
